Tuberc Respir Dis.  2013 Nov;75(5):205-209.

Effect of Prunetin on TNF-alpha-Induced MUC5AC Mucin Gene Expression, Production, Degradation of IkappaB and Translocation of NF-kappaB p65 in Human Airway Epithelial Cells

Affiliations
  • 1Department of Pharmacology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea. LCJ123@cnu.ac.kr
  • 2Pulmonology Section, Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.

Abstract

BACKGROUND
We investigated whether prunetin significantly affects tumor necrosis factor-alpha (TNF-alpha)-induced MUC5AC mucin gene expression, production, inhibitory kappa B (IkappaB) degradation and nuclear factor kappa B (NF-kappaB) p65 translocation in human airway epithelial cells.
METHODS
Confluent NCI-H292 cells were pretreated with prunetin for 30 minutes and then stimulated with TNF-alpha for 24 hours or the indicated periods. MUC5AC mucin gene expression and mucin protein production were measured by reverse transcription polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. The effect of prunetin on TNF-alpha-induced degradation of IkappaB and translocation of NF-kappaB p65 was investigated by western blot analysis.
RESULTS
We found that incubation of NCI-H292 cells with prunetin significantly inhibited mucin production and down-regulated the MUC5AC gene expression induced by TNF-alpha. Prunetin inhibited TNF-alpha-induced degradation of IkappaB and translocation of NF-kappaB p65.
CONCLUSION
This result suggests that prunetin inhibits the NF-kappaB signaling pathway, which may explain its role in the inhibition of MUC5AC mucin gene expression and production regulated by the NF-kappaB signaling pathway.

Keyword

Mucins; MUC5AC Protein, Human; Prunetin

MeSH Terms

Blotting, Western
Enzyme-Linked Immunosorbent Assay
Epithelial Cells*
Gene Expression*
Humans*
Isoflavones
Mucin 5AC
Mucins*
NF-kappa B*
Polymerase Chain Reaction
Reverse Transcription
Tumor Necrosis Factor-alpha
Isoflavones
Mucin 5AC
Mucins
NF-kappa B
Tumor Necrosis Factor-alpha

Figure

  • Figure 1 Effect of prunetin on tumor necrosis factor-α (TNF-α)-induced MUC5AC mucin production. NCI-H292 cells were pretreated with various concentrations of prunetin (1, 10, 50, and 100 µM) for 30 minutes and then stimulated with TNF-α (10 ng/mL) for 24 hours. Cell lysates were collected for measurement of MUC5AC mucin production by enzyme-linked immunosorbent assay. Three independent experiments were performed and the representative data were shown. Each bar represents the mean±SEM of three culture wells in comparison with that of the control, set at 100%. *Significantly different from control (p<0.05). †Significantly different from TNF-α alone (p<0.05). Concentration unit is µM. Pru: prunetin.

  • Figure 2 Effect of prunetin on tumor necrosis factor-α (TNF-α)-induced MUC5AC mucin gene expression. NCI-H292 cells were pretreated with 1, 10, 50, and 100 µM of prunetin for 30 minutes and then stimulated with TNF-α (10 ng/mL) for 24 hours, respectively. MUC5AC mucin gene expression was measured by reverse transcription polymerase chain reaction. As a quantitative control, Rig/S15 rRNA, which encodes a small ribosomal subunit protein, a housekeeping gene that was constitutively expressed, was used. Three independent experiments were performed and the representative data were shown. Concentration unit is µM. Pru: prunetin.

  • Figure 3 Effect of prunetin on tumor necrosis factor-α (TNF-α)-induced degradation of inhibitory kappa B alpha (IκBα). NCI-H292 cells were incubated with 50 µM prunetin for 24 hours and treated with TNF-α (50 ng/mL) for the indicated periods. Cytoplasmic extracts were prepared and analyzed by western blot using the antibody against anti-IκBα. The results shown are representative of three independent experiments. Equal protein loading was evaluated by β-actin levels.

  • Figure 4 Effect of prunetin on tumor necrosis factor-α (TNF-α)-induced nuclear translocation of nuclear factor kappa B (NF-κB) p65. NCI-H292 cells were either untreated or pretreated with 50 µM prunetin for 24 hours at 37℃ and then stimulated with TNF-α (50 ng/mL) for the indicated periods. Nuclear protein extracts were prepared and resolved on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis, transferred onto a polyvinylidene difluoride membrane, and probed with an antibody against p65. The results shown are the representative of three independent experiments. To ensure equal protein loading, the membrane was re-probed with the anti-poly(ADP-ribose) polymerase (PARP) antibody.


Reference

1. Adler KB, Li Y. Airway epithelium and mucus: intracellular signaling pathways for gene expression and secretion. Am J Respir Cell Mol Biol. 2001; 25:397–400.
2. Basbaum C, Lemjabbar H, Longphre M, Li D, Gensch E, McNamara N. Control of mucin transcription by diverse injury-induced signaling pathways. Am J Respir Crit Care Med. 1999; 160(5 Pt 2):S44–S48.
3. Heo HJ, Lee SY, Lee MN, Lee HJ, Seok JH, Lee CJ. Genistein and curcumin suppress epidermal growth factor-induced MUC5AC mucin production and gene expression from human airway epithelial cells. Phytother Res. 2009; 23:1458–1461.
4. Lee HJ, Lee SY, Bae HS, Kim JH, Chang GT, Seok JH, et al. Inhibition of airway MUC5AC mucin production and gene expression induced by epidermal growth factor or phorbol ester by glycyrrhizin and carbenoxolone. Phytomedicine. 2011; 18:743–747.
5. Lee HJ, Lee SY, Jeon BK, Lee JW, Kim YS, Lee MN, et al. Effect of platycodin D on airway MUC5AC mucin production and gene expression induced by growth factor and proinflammatory factor. Biomol Ther. 2010; 18:294–299.
6. Lee HJ, Lee SY, Lee MN, Kim JH, Chang GT, Seok JH, et al. Inhibition of secretion, production and gene expression of mucin from cultured airway epithelial cells by prunetin. Phytother Res. 2011; 25:1196–1200.
7. Jung HA, Kim AR, Chung HY, Choi JS. In vitro antioxidant activity of some selected Prunus species in Korea. Arch Pharm Res. 2002; 25:865–872.
8. Keung WM. Biochemical studies of a new class of alcohol dehydrogenase inhibitors from Radix puerariae. Alcohol Clin Exp Res. 1993; 17:1254–1260.
9. Ko WC, Shih CM, Lai YH, Chen JH, Huang HL. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochem Pharmacol. 2004; 68:2087–2094.
10. Sheikh S, Weiner H. Allosteric inhibition of human liver aldehyde dehydrogenase by the isoflavone prunetin. Biochem Pharmacol. 1997; 53:471–478.
11. Li JD, Dohrman AF, Gallup M, Miyata S, Gum JR, Kim YS, et al. Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci U S A. 1997; 94:967–972.
12. Takeyama K, Dabbagh K, Lee HM, Agusti C, Lausier JA, Ueki IF, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A. 1999; 96:3081–3086.
13. Shao MX, Ueki IF, Nadel JA. Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci U S A. 2003; 100:11618–11623.
14. Rogers DF, Barnes PJ. Treatment of airway mucus hypersecretion. Ann Med. 2006; 38:116–125.
15. Song KS, Lee WJ, Chung KC, Koo JS, Yang EJ, Choi JY, et al. Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J Biol Chem. 2003; 278:23243–23250.
16. Fischer BM, Rochelle LG, Voynow JA, Akley NJ, Adler KB. Tumor necrosis factor-alpha stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro. Am J Respir Cell Mol Biol. 1999; 20:413–422.
17. Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002; 2:725–734.
Full Text Links
  • TRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr